FDA Approves First New Molecular Entity Under National Priority Voucher Program Par FDA – Press releases
Breakthrough medical devices: information session, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 April 2026, 15:00 (CEST) to 24 April 2026, 17:00 (CEST) Par EMA – Events
